ADOC — Adocia SA Share News
0.000.00%
Last trade - 00:00- €51.42m
- €49.35m
- €1.48m
Brief: Adocia Grants Sanofi Exclusive Right To Negotiate Partnership On M1Pram For 10 Million Euros, Obtains Commitment From Investors To Provide 10 Million Euros In Financing
Brief: Listing Of Adocia Shares Suspended
Brief: Adocia Appoints Olivier Soula As CEO
Brief: Adocia Reports Financial Results Q1 2023
Brief: Adocia Is In Discussions With Its Lenders To Restructure Its Debt
Brief: Adocia Announces Successful Phase 1 Study For Biochaperone Lispro With Partner Tonghua Dongbao
Brief: Adocia Strengthens Cash Position With 6 Million Euros Through Convertible Bonds Issuance
Brief: Adocia Q3 Revenue Up At EUR 2.4 Million
Brief: Adocia's M1Pram Leads To Weight Loss For Obese People With Type 1 Diabetes
Brief: Adocia H1 Net Result Turns To Profit Of EUR 4.3 Mln
Brief: Adocia: First Cell Therapy Preclinical Proof of Concept of AdoShell Islets
Brief: Adocia Q2 Revenue Up At EUR 6.8 Mln
Brief: Adocia Says M1pram Phase 2 Trial Meets Primary Objective By Reducing Weight In Overweight People With Type 1 Diabetes
Brief: Adocia Q1 Revenue Up At EUR 0.6 Mln
Brief: Adocia: First Patient Dosed In Biochaperone Lispro Phase 3 Programme
Brief: Adocia FY Operating Loss Narrows To EUR 19.4 Mln
Brief: Adocia Sells Building In Lyon For More Than EUR 20 Mln
Brief: Adocia Announces 2021 Fourth Quarter Financial Results
Brief: Adocia FY Revenue Up At 1.4 Million Euros